C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/416 (2006.01) A61K 31/4439 (2006.01) A61K 31/454 (2006.01) A61K 31/5377 (2006.01) A61P 25/16 (2006.01) A61P 25/28 (2006.01) C07D 403/04 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2641345
Compounds of formula (IA) and (IB) are inhibitors of MARK, and hence are suitable for treatment of Alzheimer's disease.
L'invention concerne des composés représentés par les formules (IA) et (IB) qui sont des inhibiteurs de la kinase MARK, et qui sont ainsi aptes à être utilisés dans le traitement de la maladie d'Alzheimer.
Choudhury Hedaythul
Churcher Ian
Hunt Peter
Jelley Richard
Nadin Alan
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Indazole derivatives for treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazole derivatives for treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole derivatives for treatment of alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1704837